Skip to Main Content

Paper Details

Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.
Eur Urol
10
2021
DM, HRPCa, High-risk prostate cancer, PATIENT, PCSM, Radiorecurrent High-risk Prostate Cancer, men, patients, prostate cancer, radiorecurrent high-risk prostate cancer
Brachytherapy, Humans, Male, Neoplasm Grading, Prostate, Prostatic Neoplasms, Salvage Therapy
Author NameAffiliation
Rebecca G PhilipsonUniversity of California Los Angeles
Tahmineh Romerouniversity of california los angeles Division of General Internal Medicine and Health Services Research
Jessica K WongFox Chase Cancer Center
Bradley J StishMayo Clinic
Robert T DessUniversity of Michigan ann arbor
Daniel E SprattUniversity of Michigan ann arbor
Avinash PilarPrincess Margaret Cancer Centre, University of Toronto
Chandana A ReddyTaussig Cancer Institute, Cleveland Clinic
Trude B WeddeOslo University Hospital
Wolfgang LillebyOslo University Hospital
Ryan FianoSchiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University
Gregory S MerrickSchiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University
Richard G StockIcahn School of Medicine at Mount Sinai
David Jeffrey DemanesCalifornia Endocurietherapy Cancer Center
Brian J MoranChicago Prostate Cancer Center
Michelle H BraccioforteChicago Prostate Cancer Center
Phuoc T TranJohns Hopkins University School of Medicine
Santiago MartinClinica Universidad de Navarra and Program in Solid Tumors, CIMA- University of Navarra
Rafael Mart??nez-MongeClinica Universidad de Navarra and Program in Solid Tumors, CIMA- University of Navarra
Daniel J KraussOakland University William Beaumont School of Medicine
Eyad Abu-IsaUniversity of Michigan ann arbor
Luca F ValleUniversity of California Los Angeles
Natalie ChongUniversity of California Los Angeles
Thomas M PisanskyMayo Clinic
C Richard ChooMayo Clinic
Danny Y SongJohns Hopkins University School of Medicine
Stephen GrecoJohns Hopkins University School of Medicine
Curtiland DevilleJohns Hopkins University School of Medicine
Todd McNuttJohns Hopkins University School of Medicine
Theodore L DeWeeseJohns Hopkins University School of Medicine
Ashley E RossNorthwestern University Feinberg School of Medicine
Jay P CiezkiTaussig Cancer Institute, Cleveland Clinic
Derya TilkiDepartment of Urology and Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf
Robert Jeffrey KarnesMayo Clinic
Eric A KleinGlickman Urological and Kidney Institute, Cleveland Clinic
Jeffrey J TosoianThe James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine
Paul C BoutrosUniversity of California Los Angeles
Nicholas G NickolsUniversity of California Los Angeles
David ShabsovichDavid Geffen School of Medicine, University of California Los Angeles
Jesus E JuarezDavid Geffen School of Medicine, University of California Los Angeles
Patrick A KupelianUniversity of California Los Angeles
Matthew B RettigUniversity of California Los Angeles
Alejandro BerlinPrincess Margaret Cancer Centre
Jonathan D TwardHuntsman Cancer Institute at the University of Utah
Brian J DavisMayo Clinic
Robert E ReiterUniversity of California Los Angeles
Michael L SteinbergUniversity of California Los Angeles
David Elashoffuniversity of california los angeles Division of General Internal Medicine and Health Services Research
David Elashoffuniversity of california los angeles Division of General Internal Medicine and Health Services Research
Eric M HorwitzFox Chase Cancer Center
  • 1 - 50

Datasets